Activation of Alternative Cellular Energy (ACE) Pathway in the Therapy of Herpes Virus Infections

The research question to be addressed is whether indirect phototherapy based activation of the body's alternative cellular energy (ACE) pathway will lead to expedited healing of active herpes simplex virus (HSV) and herpes zoster virus (HZV)skin lesions, and also possibly inhibit both latent HSV infections and residual HZV infections.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Herpes Simplex DNA Virus Infections Herpes Zoster Herpesviridae Infections Infections Skin Diseases Skin Diseases, Infectious Skin Diseases, Viral Skin and Connective Tissue Diseases Varicella Zoster Virus Infection Virus Diseases

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinical diagnosis of active, latent or residual HSV or HZV infection

Exclusion criteria

Unwilling or unable to provide Informed Consent

Treatment and study plan

Primary outcomes

Expedited healing of active lesions

Time frame: Within 1 day following therapy

Secondary outcomes

Recurrence of lesions and/or symptoms

Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Institute of Progressive Medicine

Other

Registry information

Official study title

A Research Study Examining the Effectiveness of Distant Activation of ACE Pigments Associated With Recurrent Human Herpes Simplex Virus-Induced Skin Lesions.

Important dates

Study start: 2008
Primary completion: 2008
Study completion: 2008
First posted: Mar 25, 2008
Registry last updated: Jun 3, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed